| Financial Year |
March 31 2023 |
| Monetary Funds |
664,933,726.23 |
| Held-for-trading Financial Assets |
829,700.74 |
| Notes Receivable |
66,445,259.64 |
| Accounts Receivable |
1,392,237,075.41 |
| Advances to Suppliers |
118,855,986.90 |
| Other Receivables |
127,958,510.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
55,802,565.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
94,303,664.07 |
| Total Current Assets |
2,606,277,260.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
430,251,071.08 |
| Investment Properties |
-- |
| Fixed Assetes |
1,019,226,501.96 |
| Under-construction Projects |
54,238,581.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
536,989,798.74 |
| R&D expenses |
1,822,292.61 |
| Goodwill |
7,084,627.32 |
| Long-Term Deferred and Prepaid Expenses |
6,012,572.97 |
| Deferred Income Tax Assets |
132,211,902.13 |
| Other Non-Current Assets |
131,114,173.21 |
| Sub-Total of Non-Current Assets |
2,779,972,059.88 |
| Total Assets |
5,386,249,320.42 |
| Short-Term Loans |
1,083,180,573.51 |
| Trading Financial liabilities |
-- |
| Notes Payable |
60,977,911.33 |
| Accounts Payable |
527,885,826.23 |
| Accounts Received In Advance |
1,171,099.86 |
| Employee Compensation Payable |
6,046,373.48 |
| Taxes Payable |
33,785,902.23 |
| Interest Payable |
5,516,277.62 |
| Dividend Payable |
-- |
| Other payables |
218,943,595.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
45,490,367.82 |
| Other Current Liabilities |
65,312,514.28 |
| Sub-Total of Current Liabilities |
2,065,548,388.68 |
| Long-term Loans |
42,215,134.84 |
| Bonds Payable |
627,419,972.43 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
636,061.95 |
| Deferred Income Tax Liabilities |
3,618,760.81 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
721,540,948.04 |
| Total Liabilities |
2,787,089,336.72 |
| Paid-In Capital(Or Share Stock) |
560,349,223.00 |
| Capital Surplus |
371,000,312.87 |
| Surplus Reserve |
227,682,697.11 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,040,652,393.38 |
| Minority Stockholder's Interest |
196,708,367.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,402,451,616.70 |
| Owner's Equity（Stockholder's Equity） |
2,599,159,983.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,386,249,320.42 |
